John M Limongelli
CIK 1445234 · SVP & General Counsel · last filed 2021-03-19
John M Limongelli is a SVP & General Counsel who has filed 20 SEC Form 4 insider transactions across 3 companies since 2008. The most recent filing, for NEOS, was dated Mar 19, 2021. Across all open-market trades the lifetime net is +$48.4K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $9.5M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$9.47M
3
20
$48.4K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Neos Therapeutics, Inc. (NEOS) Delisted | SVP & General Counsel | 0 | $1.15 | $0 | $0 | 4 | 2021-03-19 |
| TRVN | Sr. VP,General Counsel & CAO | 12,000 | $0.01 | $133 | $48.4K | 8 | 2018-03-02 |
| RPRX | SVP, General Counsel & Secr | 172,500 | $54.87 | $9.47M | $0 | 4 | 2010-09-13 |
Recent Filings
20 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-03-19 | Neos Therapeutics, Inc. (NEOS) Delisted | Disp (D) | −83,015 | $0 | EDGAR |
| 2021-03-16 | Neos Therapeutics, Inc. (NEOS) Delisted | Tax (F) | −16,985 | -$14.3K | EDGAR |
| 2020-03-04 | Neos Therapeutics, Inc. (NEOS) Delisted | Grant (A) | +100,000 | $0 | EDGAR |
| 2019-03-22 | Neos Therapeutics, Inc. (NEOS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-03-02 | TRVN | Grant (A) | — | $0 | EDGAR |
| 2017-08-29 | TRVN | Grant (A) | — | $0 | EDGAR |
| 2017-03-03 | TRVN | Grant (A) | — | $0 | EDGAR |
| 2017-01-06 | TRVN | Grant (A) | — | $0 | EDGAR |
| 2016-03-07 | TRVN | Grant (A) | — | $0 | EDGAR |
| 2015-03-19 | TRVN | Grant (A) | — | $0 | EDGAR |